Rabies: Clinical Trials

29 trials for Rabies, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

21 completed, 5 not yet recruiting, 2 unknown, 1 active not recruiting. 29 Phase 3, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 329Completed 21, Not yet recruiting 5, Unknown 2, Active not recruiting 1
Phase 22Completed 1, Not yet recruiting 1

Follow Rabies: new trials by email Literature Review of Rabies trials Research Report on Rabies

Trials (filtered) newest first · largest first

All 29 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Boostability Assessment of Three Rabies Pre-Exposure Regimens in Healthy Volunteers 5 Years Following Priming.
Booster vaccination - Rabies (Healthy Volunteers)
Phase 3Not yet recruitingInstitute of Tropical Medicine, Belgium5612026-05-152026-03-06
Phase IIIb Clinical Trial to Evaluate Lot-to-lot Consistency of Sinovac Rabies Vaccine
Sinovac rabies vaccine - Rabies (Healthy Volunteers)
Phase 3Not yet recruitingSinovac Biotech Co., Ltd9122026-03-042026-02-17
Immunogenicity and Safety of Rabies Vaccine (Serum-free Vero Cell) in a Pre-exposure Prophylaxis Regimen
Rabies Vaccine (Serum-free Vero Cell), Freeze-dried, Verorab® - Rabies
Phase 3Not yet recruitingSinovac Biotech Co., Ltd3902026-03-012025-07-08
Immunogenicity and Safety of Rabies Vaccine (Serum-free Vero Cell) in a Simulated Post-exposure Prophylaxis Regimen
Rabies vaccine, Verorab® - Rabies (Healthy Volunteers)
Phase 3Not yet recruitingSinovac Biotech Co., Ltd3902026-03-012025-07-09
A Clinical Trial of Rabies Vaccine(Human Diploid Cell)for Human Use,Freeze-dried in a Population Aged 10 to 60 Years
Rabies Vaccine(Human Diploid Cell)for Human Use,Freeze-dried - Rabies
Phase 3Active not recruitingAb&B Bio-tech Co., Ltd.JS30002026-02-262026-10-28
Safety and Immunogenicity of ID vs IM Rabies Vaccine
Rabies vaccine - Rabies
Phase 2 / Phase 3Not yet recruitingInternational Centre for Diarrhoeal Disease Research, Bangladesh902025-12-152026-01-15
Clinical Trial of Freeze-dried Human Rabies Vaccine (Human Diploid Cells)
Freeze-dried human rabies vaccine (human diploid cells) - Rabies
Phase 3CompletedNingbo Rongan Biological Pharmaceutical Co., Ltd.30002025-07-302026-11-12
A Study to Evaluate a PIKA Rabies Vaccine(Vero Cell)for Human Use,Freeze-dried
PIKA Rabies Vaccine (Vero Cell) for Human use, Freeze-dried, Chirorab - Rabies, Prevention
Phase 3UnknownYisheng Biopharma (Singapore) Pte. Ltd.45002023-09-222024-07-23
Clinical Trial of Freeze-dried Human Rabies Vaccine (Without Serum Vero Cells)
5-dose group of test vaccine, 5-dose group of control vaccine, 4-dose A group of test vaccine - Rabies
Phase 3UnknownNingbo Rongan Biological Pharmaceutical Co., Ltd.24602023-08-012023-08-09
Study to Evaluate GR1801's Efficacy and Safety
GR1801, Human Rabies Immunoglobulin(HRIG), Rabies Vaccine - Rabies Post-exposure Prophylaxis
Phase 3CompletedGenrix (Shanghai) Biopharmaceutical Co., Ltd.12002022-10-212024-09-25
Immunogenicity and Safety Assessment of Rabies Vaccine (Vero Cell) for Human Use, Freeze-dried
Sinovac rabies vaccine, Marketed rabies vaccine - Rabies (Healthy Volunteers)
Phase 3CompletedSinovac Biotech Co., Ltd20402021-08-272026-01-22
Study of Purified Vero Rabies Vaccine Compared With a Reference Rabies Vaccine as Simulated Rabies Post-Exposure Prophylaxis in Adults in Thaïland
Purified vero rabies vaccine - serum free, Purified inactivated rabies vaccine, Human rabies immunoglobulins - Rabies (Healthy Volunteers)
Phase 3CompletedSanofi Pasteur, a Sanofi Company2012020-10-112025-09-19
A Phase III Clinical Study to Evaluate SYN023's Efficacy and Safety
SYN023, Human Rabies Immune Globulin (HRIG), Rabies Vaccine - Rabies, Communicable Disease
Phase 3CompletedSynermore Biologics (Suzhou) Co., Ltd.10002020-09-232023-04-21
Study of Purified Vero Rabies Vaccine Compared With a Reference Rabies Vaccine as Simulated Rabies Post-Exposure Prophylaxis in Adult and Pediatric Population in Thaïland
Purified vero rabies vaccine - serum free VRVg-2, Purified inactivated rabies vaccine, Equine rabies immunoglobulins (ERIG) (only Group 3 and Group 4) - Rabies (Healthy Volunteers)
Phase 3CompletedSanofi Pasteur, a Sanofi Company4032020-08-042025-09-19
Study of Purified Vero Rabies Vaccine Compared With Two Reference Rabies Vaccines, Given in a Pre-exposure Regimen to Children and Adults and as Single Booster Dose to a Subset of Adults
Purified vero rabies vaccine - serum free - VRVg-2, Purified inactivated rabies vaccine - Verorab®, Purified inactivated rabies vaccine - Imovax® Rabies - Rabies, Healthy Volunteers
Phase 3CompletedSanofi Pasteur, a Sanofi Company17082019-10-212026-02-10
Study of Purified Vero Rabies Vaccine Compared With Two Reference Rabies Vaccines in a Simulated Post-Exposure Regimen in Adults
VRVg-2, Purified Inactivated Rabies Vaccine, Human Diploid Cell Vaccine (HDCV) - Rabies (Healthy Volunteers)
Phase 3CompletedSanofi Pasteur, a Sanofi Company6402019-07-012025-09-18
Post-marketing Study of KamRAB Administered as a Single Dose With Active Rabies Vaccine in Children Exposed to Rabies
KamRAB - HRIG - Rabies
Phase 3CompletedKamada, Ltd.302016-08-012021-09-05
A Phase 3 Clinical Trial to Evaluate Long-term Immunogenicity and Boostability of Purified Chick-Embryo Cell Rabies Vaccine in Adults Following Primary Series of Pre/Exposure Prophylaxis.
Rabipur, Blood sampling, Purified Chick-Embryo Cell Rabies Vaccine - Virus Diseases, Rabies
Phase 3CompletedGlaxoSmithKline4592015-10-052024-07-18
Phase II/III Study of the Safety and Effectiveness of HRIG With Active Rabies Vaccine in Healthy Subjects
Active rabies vaccine (US-FDA approved) - Rabies
Phase 2 / Phase 3CompletedKamada, Ltd.1182013-04-012021-09-29
A Randomized, Open-label Study Comparing Two Different Rabies Vaccine Schedules in Chinese Children and Older Adults
Zagreb, Essen - Rabies
Phase 3CompletedNovartis Vaccines6442012-09-012014-05-20

Showing 20 of 29. Sign in to see all of them.

Narrower conditions

Encephalitis, Japanese (2)  ·  Virus Diseases (2)  ·  Communicable Diseases (1)  ·  Meningitis, Meningococcal (1)  ·  Meningococcal Infections (1)  ·  Mononegavirales Infections (1)  ·  RNA Virus Infections (1)  ·  Rhabdoviridae Infections (1)  ·  Typhoid Fever (1)  ·  Yellow Fever (1)

Broader conditions

Infections (29)  ·  Mononegavirales Infections (28)  ·  RNA Virus Infections (28)  ·  Rhabdoviridae Infections (28)  ·  Virus Diseases (27)  ·  Arbovirus Infections (2)  ·  Brain Diseases (2)  ·  Central Nervous System Diseases (2)  ·  Central Nervous System Infections (2)  ·  Central Nervous System Viral Diseases (2)  ·  Encephalitis (2)  ·  Encephalitis, Arbovirus (2)  ·  Encephalitis, Viral (2)  ·  Flaviviridae Infections (2)  ·  Flavivirus Infections (2)

Interventions

Rabies Vaccines (10)  ·  Freeze Drying (2)  ·  Blood Specimen Collection (1)  ·  Immunization, Secondary (1)  ·  Japanese Encephalitis Vaccines (1)  ·  MenACWY-CRM vaccine (1)  ·  Vi polysaccharide vaccine, typhoid (1)  ·  Yellow Fever Vaccine (1)  ·  hemoglobin A2 Zagreb (1)

Sponsors

Sanofi Pasteur, a Sanofi Company (6)  ·  Novartis Vaccines (4)  ·  Sinovac Biotech Co., Ltd (4)  ·  Institute of Tropical Medicine, Belgium (2)  ·  Kamada, Ltd. (2)  ·  Ningbo Rongan Biological Pharmaceutical Co., Ltd. (2)  ·  Ab&B Bio-tech Co., Ltd.JS (1)  ·  Genrix (Shanghai) Biopharmaceutical Co., Ltd. (1)  ·  GlaxoSmithKline (1)  ·  International Centre for Diarrhoeal Disease Research, Bangladesh (1)  ·  Jiangsu Province Centers for Disease Control and Prevention (1)  ·  Novartis (1)  ·  Provincial Public Health Office, Phetchabun (1)  ·  Synermore Biologics (Suzhou) Co., Ltd. (1)  ·  Yisheng Biopharma (Singapore) Pte. Ltd. (1)

Countries

China (12)  ·  Thailand (4)  ·  Germany (3)  ·  Pakistan (3)  ·  Austria (2)  ·  Belgium (2)  ·  Philippines (2)  ·  Switzerland (2)  ·  United States (2)  ·  Bangladesh (1)  ·  Czechia (1)  ·  France (1)

Top investigators

Ume Sughra, Dr. (2)  ·  Mark Matson, M.D. (1)  ·  Patrick Soentjens, MD (1)  ·  Shomik Maruf, MSc (1)  ·  Thavatchai Kamoltham, MD (1)  ·  Xiaoqiang Liu, MD, PhD (1)  ·  Xiaoqiang Liu, PHD (1)  ·  Yuemei Hu (1)

Results publications

PMID 17643772, PMID 24148575, PMID 24873986, PMID 25308927, PMID 25483635, PMID 25692350, PMID 26005163, PMID 26994987, PMID 29939243, PMID 30890382, PMID 33091433, PMID 34483020, PMID 38478634, PMID 39587931, PMID 40479926, PMID 40812204, PMID 42764163

NIH funding

2015 (1), 2018 (1), 2019 (1), 2025 (1)